Mylan NV Chairman Opens Up About Rejection Of Teva Pharmaceutical Industries Ltd

Mylan NV (NYSE:MYL) currently occupies a central position in the three-way acquisition struggle that involves Israel-based Teva Pharmaceuticals Industries Ltd (ADR) (NYSE:TEVA) and Perrigo Company plc (NYSE:PRGO). In an interview to the Pittsburgh Business Times on Wednesday, Mylan executive chairman Robert Coury spoke in detail about his reason for refusing Teva's bid for his company.